NI
Nadiya Ishnazarova
Principal at M Ventures
Netherlands
Overview
Nadiya Ishnazarova is a Principal at M Ventures with a background in biochemistry and genetics, specializing in biotechnology investments. She has served on the boards of various companies in the biotech sector and holds a Ph.D. in Biochemistry from the University of Oxford, showcasing a strong track record in strategic decision-making and leadership within the industry.
Work Experience
Principal
2024 - Current
Associate
2021 - 2024
Board Observer
2024
Board Member
2023 - 2024
Board Member
2023
Board Member
2023
ImmuneBridge is developing allogeneic immunotherapies for cancer.
Raised $12,000,000.00 from Gaingels, Insight Partners, M Ventures, One Way Ventures, Pioneer Fund, Healthspan Capital and Quiet Capital.
Board Member
2023
Board Observer
2023
Board Observer
2023
Board Observer
2022
Board Observer
2022
Board Observer
2021